Scinai Immunotherapeutics’ Key Shareholder Meeting
Company Announcements

Scinai Immunotherapeutics’ Key Shareholder Meeting

Scinai Immunotherapeutics (SCNI) has released an update.

Scinai Immunotherapeutics Ltd. has announced an Extraordinary Meeting of Shareholders scheduled for August 12, 2024, to discuss key proposals, including amendments to the company’s articles of association for preferred share creation and a restricted share unit grant for CEO Amir Reichman. Shareholders of record as of July 3, 2024, are entitled to vote, and the board recommends a vote in favor of the proposals. The meeting’s outcomes could significantly impact the company’s corporate governance and executive compensation structure.

For further insights into SCNI stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskScinai Immunotherapeutics to Hold Annual Shareholder Meeting
TipRanks Auto-Generated NewsdeskScinai Immunotherapeutics Licenses Global Rights
TipRanks Auto-Generated NewsdeskScinai Immunotherapeutics Restructures Debt, Eyes Growth
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App